Physician

Matthew Henry Oltmanns, M.D.

According to 2025 Medicare claims, Matthew Oltmanns, M.D. (NPI: 1063603322) practices ophthalmology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is RETINA SPECIALISTS OF ALABAMA LLC (NPI: 1437194867; TIN: 631248335) and primary practice location at 35233-2313.

Oltmanns' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 826 traditional Medicare patients, billed 17,671 HCPCS/CPT codes, and received $1,586,700 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,247 prescription claims across 436 beneficiaries totaling $64,497 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $176. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $519,285 to $1,586,700. Similarly, Part D prescription costs have risen steadily, from $26,971 to $64,497. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	934	9,386	$519,285
2016	917	10,694	$602,007
2017	788	10,187	$733,974
2018	795	9,299	$961,943
2019	894	10,261	$1,279,042
2020	783	9,275	$1,258,606
2021	839	9,286	$1,425,614
2022	897	9,988	$1,599,168
2023	863	16,544	$1,673,717
2024	826	17,671	$1,586,700

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	172	524	$26,971
2016	245	612	$34,980
2017	269	698	$34,950
2018	314	822	$39,760
2019	342	876	$47,951
2020	371	1,056	$51,445
2021	404	1,061	$45,553
2022	409	1,093	$59,219
2023	404	1,170	$74,917
2024	436	1,247	$64,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	327	1,366	$84
92014	Established patient complete exam of visual system	413	723	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	405	617	$57
J9035	Injection, bevacizumab, 10 mg	196	748	$55
92134	Imaging of retina	729	2,228	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	309	12,771	$18,084
Bromfenac Sodium	Bromfenac Sodium	52	964	$6,263
Alphagan P	Brimonidine Tartrate	14	616	$5,106
Difluprednate	Difluprednate	39	995	$4,158
Loteprednol Etabonate	Loteprednol Etabonate	16	509	$3,715

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$176	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Henry Oltmanns, M.D.?

Tedicare shows public-source Medicare data for Matthew Henry Oltmanns, M.D. (NPI 1063603322), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Henry Oltmanns, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Henry Oltmanns, M.D.?

Matthew Henry Oltmanns, M.D. is linked to RETINA SPECIALISTS OF ALABAMA LLC (billing NPI 1437194867) in the available physician profile data.

Does Matthew Henry Oltmanns, M.D. have Open Payments data?

Matthew Henry Oltmanns, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.